Associate Principal Scientist, Biopharmaceutics
AstraZeneca
Macclesfield, United Kingdom
Kate is an Associate Principal Scientist within Biopharmaceutics, New Modality & Parenteral Development at AstraZeneca Macclesfield and has over 25 years’ industry experience in oral and complex parenteral drug product development. Kate’s role involves leading the biopharmaceutics strategy development for subcutaneously (SC) administered new modalities, focussing on establishing and integrating novel SC biopharmaceutics tools and developing bioequivalence strategies to allow for smarter and flexible SC drug product development.
Disclosure information not submitted.
Workshop: Debunking the Myths of Subcutaneous Drug Delivery
Monday, July 8, 2024
1:00 PM – 5:00 PM CET
